P

Precipio
D

PRPO

10.150
USD
0.66
(6.95%)
Market Closed
Volume
1,291
EPS
0
Div Yield
-
P/E
-6
Market Cap
15,045,680
Related Instruments
    A
    APT
    0.10000
    (1.82%)
    5.60000 USD
    A
    AYTU
    -0.04000
    (-2.90%)
    1.34000 USD
    B
    BNGO
    0.01500
    (0.28%)
    5.36500 USD
    C
    CODX
    0.01720
    (2.46%)
    0.71700 USD
    V
    VERU
    -0.01770
    (-2.97%)
    0.57900 USD
    V
    VSTM
    0.11500
    (2.06%)
    5.68500 USD
    More
News

Title: Precipio

Sector: Healthcare
Industry: Diagnostics & Research
Precipio Inc is a healthcare solutions company focused on cancer diagnostics. It focuses on addressing the problem of cancer misdiagnoses by developing solutions to mitigate the root causes of this problem in the form of diagnostic products, reagents and services. The company operates Clinical Laboratory Improvement Amendments laboratories in both the New Haven, Connecticut and Omaha, Nebraska locations providing essential blood cancer diagnostics to office-based oncologistsin many states nationwide. It provides new technologies to the oncology diagnostic laboratory market in the form of HemeScreen and IV-Cell product offerings. The company generates the majority of its revenue from third-party payers.
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.